Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference Pharmaceutical Investing
AbbVie Announces Provincial Reimbursement for VENCLEXTA® with Obinutuzumab for Patients with Previously Untreated Chronic Lymphocytic Leukemia in Alberta, Saskatchewan, British Columbia, and Manitoba Pharmaceutical Investing
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance Pharmaceutical Investing
Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference Life Science Investing
AbbVie Submits Supplemental New Drug Application to U.S. FDA for cariprazine for the Adjunctive Treatment of Major Depressive Disorder Pharmaceutical Investing
Abbott's CardioMEMS HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
